Zoetis Stock Forecast
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:02 PM ET · Delayed 15 min
Pre-market: 72.93 -0.21%
ZTS analyst consensus
Consensus (17 analysts)
buy
Avg. price target
$96.00+31.36%
- Strong buy 4
- Buy 4
- Hold 9
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 17 Wall Street analysts covering Zoetis (2026-10-07), 8 rate the stock a buy or strong buy, 9 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $96.00, with a high estimate of $155.00 and a low estimate of $80.00. The average target implies upside of 31.4% from the current price of $73.08.
The spread between the highest and lowest targets is 93.8%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ZTS.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 4 | 24% |
| Buy | 4 | 24% |
| Hold | 9 | 53% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $80.00 | +9.47% |
| Average target | $96.00 | +31.36% |
| High target | $155.00 | +112.10% |